CrushSCI.com
136.1Average days
128Median days
39Fastest days
243Longest days
1302025 publications

Paper Review Records

All Paper Review Records

17 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

145 days

TREM2 c·3G>A promotes aberrant microglial-endothelial signaling, impairs BBB integrity, and enhances Aβ and Tau accumulation

Authors
Han-Chen Yang; Christabel Xin Tan; Ouyang Chen; Jing Zhang; Yu-Sen Deng; Zhibin Wang; Liwei Sun; Ye Liang; Yusheng Wei; Yunsi Yin; Yuhang Zhang; Bao-Dong He; Rui-Yang Li; Run Di; Chuheng Jiang; Meng Wang; Zhi-Qing David Xu; Chang-Mei Liu; Yi Xing; Chunlin Li; Qi Qin; Zhao-Qian Teng; Yi TangShow moreShow less
Affiliations
1. Department of Neurology & Innovation Center for Neurological Disorders, Xuanwu Hospital, Capital Medical University, National Center for Neurological Disorders, Beijing, China; 2. Beijing Key Laboratory of Digital Medicine for Cognitive Disorders, Beijing, China; 3. Chinese Institute for Brain Research, Beijing, China; 4. State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, China; 5. Life Sciences Institute, University of Michigan, Ann Arbor, USA; 6. School of Biomedical Engineering, Beijing Key Laboratory of Fundamental Research on Biomechanics in Clinical Application, Capital Medical University, Beijing, China; 7. Core Facility of the State Key Laboratory of Membrane Biology, Peking University, Beijing, China; 8. College of Life Sciences, Peking University, Beijing, China; 9. Department of Neurobiology, Beijing Key Laboratory of Neural Regeneration and Repair, Beijing Institute for Brain Disorders, Capital Medical University, Beijing, ChinaShow moreShow less
Source PDF DOI Publisher page
125 days

Revealing white matter hyperintensities-related faster posterior cortical tau accumulation in Alzheimer’s Disease

Authors
Yue Cai; Jie Yang; Chao Huang; Li Liang; Lili Fang; Xin Zhou; Wei Liu; Pan Sun; Anqi Li; Mingxu Li; Zhengbo He; Yalin Zhu; Yiying Wang; Yu Wang; Chenfei Ye; Zhen Liu; Minjie Tan; Ting Ma; Ying Han; Tengfei GuoShow moreShow less
Affiliations
1. Institute of Neurological and Psychiatric Disorders, Shenzhen Bay Laboratory, Shenzhen, China; 2. Department of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, China; 3. Division of Neurology, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, China; 4. State Key Laboratory of Digital Medical Engineering, Key Laboratory of Biomedical Engineering of Hainan Province, School of Biomedical Engineering, Hainan University, Sanya, China; 5. School of Electronic and Information Engineering, Harbin Institute of Technology (Shenzhen), Shenzhen, China; 6. Division of Life Science, The Hong Kong University of Science and Technology, Kowloon, China; 7. Department of Neurology, The First Affiliated Hospital of Anhui Medical University, Hefei, China; 8. School of Life Science and Technology, Harbin Institute of Technology, Harbin, China; 9. MRI R&D, Neusoft Medical Systems Co., Ltd., Shanghai, China; 10. School of Biomedical Engineering, Harbin Institute of Technology (Shenzhen), University Town, Shenzhen, China; 11. Department of Neurology, The Affiliated Hospital of Hangzhou Normal University, Hangzhou, China; 12. Department of Geriatrics of Changji People’s Hospital, Changji, ChinaShow moreShow less
Source PDF DOI Publisher page
243 days

SALL1 as a marker for distinguishing microglia from blood-derived myeloid cells in stroke brain scRNA-seq data

Authors
Chu-Yan Zhang; Yi-Ming Lu; Heng Zhang; Yi-Sheng Li; Luo-Yi-Fan He; Yi-Yao Gao; Mu-Zhou Xue; Zi-Yu Wang; Zi-Bo Tang; Li-Li Feng; Jiali Wang; Yi-Xuan ZhangShow moreShow less
Affiliations
1. Medical Basic Research Innovation Center for Cardiovascular and Cerebrovascular Diseases, Ministry of Education, China, School of Pharmacy, Nanjing Medical University, Nanjing, China; 2. Department of Hematology and Oncology, Children’s Hospital of Nanjing Medical University, Nanjing, China; 3. Children’s Hospital of Nanjing Medical University, Nanjing, China; 4. International Joint Laboratory for Drug Target of Critical Illnesses, School of Pharmacy, Nanjing Medical University, Nanjing, China; 5. Northern Jiangsu Institute of Clinical Medicine, The Affiliated Huaian No.1 People’s Hospital of Nanjing Medical University, Huaian, ChinaShow moreShow less
Source PDF DOI Publisher page
183 days

In vivo detection of pathologic α- synuclein and TDP-43 in the skin and olfactory mucosa of a patient with Parkinson’s disease-like phenotype carrying the p.Thr272Serfs*10 GRN mutation

Authors
Paola Caroppo; Vittoria Aprea; Cristina Villa; Ilaria Linda Dellarole; Aurora Romeo; Giacomina Rossi; Arianna Ciullini; Anna Burato; Sara Prioni; Marina Grisoli; Giuseppe Legname; Giulia Simmini; Alessia Luppino; Samanta Mazzetti; Fabio Moda; Grazia DevigiliShow moreShow less
Affiliations
1. Neurology 8 – Dementia and Degenerative Diseases of CNS Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy; 2. SSD Laboratory Medicine-Laboratory of Clinical Pathology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy; 3. Laboratory of Prion Biology, Department of Neuroscience, Scuola Internazionale Superiore Di Studi Avanzati (SISSA), Trieste, Italy; 4. Clinical Neuropsychology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy; 5. Neuroradiology Unit – Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy; 6. Neurology 1 Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy; 7. Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, ItalyShow moreShow less
Source PDF DOI Publisher page
62 days

Dynamic [ 18 F]PI-2620 recording facilitates prediction of β-amyloid positivity and simultaneous staging of tau and neurodegeneration

Authors
Johannes Gnörich; Julia Kusche-Palenga; Agnes Kling; Amir Dehsarvi; Angela Bronte; Lukas Frontzkowski; Artem Zatcepin; Mirlind Zaganjori; Florian Schöberl; Sebastian N. Roemer-Cassiano; Boris-Stephan Rauchmann; Carolin Kurz; Carla Palleis; Alexander M. Bernhardt; Alexander Jäck; Sabrina Katzdobler; Maximilian Scheifele; Theresa Bauer; Gérard N. Bischof; Thilo van Eimeren; Alexander Drzezga; Jan Häckert; Robert Perneczky; Michael Rullmann; Katharina Buerger; Rudolf A. Werner; Andreas Zwergal; Johannes Levin; Peter Bartenstein; Osama Sabri; Henryk Barthel; Sophia Stöcklein; Günter Höglinger; Nicolai Franzmeier; Matthias BrendelShow moreShow less
Affiliations
1. Department of Nuclear Medicine, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany; 2. German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany; 3. Institute for Stroke and Dementia Research, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany; 4. Universidad de Navarra, Pamplona, Spain; 5. Department of Neurology, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany; 6. Department of Psychiatry and Psychotherapy, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany; 7. Munich Cluster for Systems Neurology (SyNergy), Munich, Germany; 8. Department of Nuclear Medicine, Faculty of Medicine, University Hospital Cologne, Cologne, Germany; 9. Institute of Neuroscience and Medicine (INM-2), Molecular Organization of the Brain, Forschungszentrum Jülich, Germany; 10. German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany; 11. Department of Psychiatry, Psychotherapy and Psychosomatics, Medical Faculty, University of Augsburg, BKH Augsburg, Augsburg, Germany; 12. Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, Sheffield, UK; 13. Ageing Epidemiology Research Unit (AGE), School of Public Health, Imperial College London, London, UK; 14. Department of Nuclear Medicine, University Hospital Leipzig, Leipzig, Germany; 15. The Russell H Morgan Department of Radiology and Radiological Sciences, Division of Nuclear Medicine, Johns Hopkins School of Medicine, Baltimore, USA; 16. German Center for Vertigo and Balance Disorders, DSGZ, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany; 17. Department of Radiology, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany; 18. The Sahlgrenska Academy, Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, University of Gothenburg, Mölndal and Gothenburg, SwedenShow moreShow less
Source PDF DOI Publisher page
160 days

Retromer-targeted therapy for neurodegenerative diseases

Authors
Michele Persico; Sophronea Tuithung; Alejandra Lorenzo; Darynaisha Crawford; Simona Eleuteri; David K. SimonShow moreShow less
Affiliations
1. Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, USA; 2. Department of Neurology, Emory University School of Medicine, Atlanta, USAShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does Molecular Neurodegeneration take to review a manuscript?

As of 2026-11-18, CrushSCI has 17 complete review records for Molecular Neurodegeneration. The fastest paper went from submission to acceptance in 39 days (Breaking the glial loop: astrocytic PAD2 and citrullinated vimentin drive microglial dysfunction in Alzheimer’s disease, received 2026-05-28, accepted 2026-07-06); the slowest took 243 days. The average is 136.1 days and the median is 128 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.